Skip to main content
Premium Trial:

Request an Annual Quote

Eurofins Acquiring GATC Biotech

NEW YORK (GenomeWeb) – Sequencing services firm GATC Biotech said today it is being acquired by Eurofins Scientific.

The deal is expected to close in July 2017 and will expand Eurofins' capabilities in areas including DNA sequencing and genetic testing. The purchase price was not disclosed.

"This transaction is a demonstration of Eurofins' commitment to genomics services," Eurofins CEO Gilles Martin said in a statement. "We believe that advances in gene sequencing will continue to drive innovations not only in clinical diagnostics, but in the broader bioanalytical testing market as well."

GATC has 140 employees at two sites and provides services to some 10,000 customers. The company's annual revenues are in the range of €20 million ($22.5 million).

"We are excited to be joining the Eurofins family of laboratories and look forward to the next phase of our development within the Group," Peter Pohl, GATC CEO and co-founder, said in a statement. "We are confident that with access to Eurofins’ global network and technical competencies, we should be able to expand our analytical portfolio and services to benefit all our existing and future clients."

The Scan

Panel Recommends Pfizer-BioNTech Vaccine for Kids

CNN reports that the US Food and Drug Administration advisory panel has voted in favor of authorizing the Pfizer-BioNTech SARS-CoV-2 vaccine for children between 5 and 11 years old.

Sharing How to Make It

Merck had granted a royalty-free license for its COVID-19 treatment to the Medicines Patent Pool, according to the New York Times.

Bring it Back In

Bloomberg reports that a genetic analysis has tied a cluster of melioidosis cases in the US to a now-recalled aromatherapy spray.

Nucleic Acids Research Papers on SomaMutDB, VThunter, SCovid Databases

In Nucleic Acids Research this week: database of somatic mutations in normal tissue, viral receptor-related expression signatures, and more.